Telo Genomics Corp (TSE:TELO)
TSXV:TELO
Holding TSE:TELO?
Track your performance easily

Telo Genomics Corp (TELO) Financial Statements

18 Followers

Telo Genomics Corp Financial Overview

Telo Genomics Corp's market cap is currently ―. The company's EPS TTM is C$-0.041; its P/E ratio is -3.97; Telo Genomics Corp is scheduled to report earnings on October 29, 2024, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBITC$ -606.06KC$ -835.14KC$ -672.55KC$ -854.87KC$ -710.88K
EBITDAC$ -596.19KC$ -824.60KC$ -662.24KC$ -844.70KC$ -701.88K
Net Income Common StockholdersC$ -606.06KC$ -835.14KC$ -672.55KC$ -854.87KC$ -710.88K
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 690.88KC$ 1.30MC$ 1.98MC$ 2.67MC$ 727.58K
Total AssetsC$ 856.53KC$ 1.53MC$ 2.20MC$ 2.93MC$ 979.58K
Total DebtC$ 0.00C$ 32.50KC$ 32.50KC$ 32.50KC$ 40.00K
Net DebtC$ -690.88KC$ -1.26MC$ -1.95MC$ -2.64MC$ -687.58K
Total LiabilitiesC$ 257.05KC$ 321.36KC$ 221.14KC$ 312.87KC$ 163.77K
Stockholders EquityC$ 599.49KC$ 1.21MC$ 1.98MC$ 2.61MC$ 815.81K
Cash Flow-
Free Cash FlowC$ -581.77KC$ -682.63KC$ -693.18KC$ -673.24KC$ -692.83K
Operating Cash FlowC$ -581.77KC$ -682.63KC$ -690.38KC$ -672.23KC$ -664.84K
Investing Cash Flow--C$ -2.80KC$ -1.01KC$ -27.99K
Financing Cash FlowC$ -22.50K-C$ -2.28KC$ 2.62M-
Currency in CAD

Telo Genomics Corp Earnings and Revenue History

Telo Genomics Corp Debt to Assets

Telo Genomics Corp Cash Flow

Telo Genomics Corp Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis